CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study Age-specific gender differences in early mortality following ST-segment elevation myocardial infarction in China Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study Early Natural History of Spontaneous Coronary Artery Dissection Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization

Clinical Trial2025 Aug 19;14(16):e041521.

JOURNAL:J Am Heart Assoc. Article Link

Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques

PJ Karhunen, T Pessi, S Hörkkö et al. Keywords: bacteria; biofilm; coronary heart disease; immune system; myocardial infarction.